Stereotaxis, Inc., a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced it has extended the maturity of its revolving credit facility with Silicon Valley Bank (SVB) by three years to March 31, 2018. The...
view press release
March 30, 2015, 07:21 AM
|
Stereotaxis, Inc. has completed the renewal of its revolving credit facility with Silicon Valley Bank (SVB). Under an amended credit agreement, Stereotaxis will extend its $3 million asset based revolving line of credit with SVB through March 31...
view press release
September 03, 2013, 07:24 AM
|